The present invention relates to a pharmaceutical composition comprising ciprofloxacin or salts of thereof and amoxycillin or salts of thereof and other pharmaceutical excipients. The present invention provides more reliable effect against all bacteria, including the most commonly causative streptococci, responsible for especially respiratory tract infections. The invention makes up for the weakness of ciprofloxacin against streptococci.
